Skip to content
6-K

Foreign Interim / Material

Haoxi Health Technology Limited HAO

0001213900-25-034629

← back to feed
Filed
Apr 23, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Dec 31, 2024 1.81M sh
Shares Diluted Q2 2025 · Dec 31, 2023 1.18M sh
Capex Q2 2025 · Dec 31, 2024 $5.14K
Capex Q2 2025 · Dec 31, 2023 $16.16K
Operating Cash Flow Q2 2025 · Dec 31, 2024 −$2.25M
Operating Cash Flow Q2 2025 · Dec 31, 2023 $301K
Short Term Debt Q2 2025 · Dec 31, 2024 $1.12M
Short Term Debt Q2 2025 · Jun 30, 2024 $833.52K
Stockholders Equity Q2 2025 · Dec 31, 2024 $18.74M
Stockholders Equity Q2 2025 · Jun 30, 2024 $11.27M
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.72M
Stockholders Equity Q2 2025 · Jun 30, 2023 $1.57M
Current Liabilities Q2 2025 · Dec 31, 2024 $3.29M
Current Liabilities Q2 2025 · Jun 30, 2024 $3.87M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.32M
Total Liabilities Q2 2025 · Jun 30, 2024 $4.23M
Current Assets Q2 2025 · Dec 31, 2024 $19.82M
Current Assets Q2 2025 · Jun 30, 2024 $15.38M
Total Assets Q2 2025 · Dec 31, 2024 $22.07M
Total Assets Q2 2025 · Jun 30, 2024 $15.51M
Eps Diluted Q2 2025 · Dec 31, 2024 −$0.13
Eps Diluted Q2 2025 · Dec 31, 2023 $0.64
Eps Basic Q2 2025 · Dec 31, 2024 −$0.13
Eps Basic Q2 2025 · Dec 31, 2023 $0.64
Sga Expense Q2 2025 · Dec 31, 2024 $509.92K
Sga Expense Q2 2025 · Dec 31, 2023 $331.61K
Rd Expense Q2 2025 · Dec 31, 2024 $67.56K
Rd Expense Q2 2025 · Dec 31, 2023 $30.84K
Net Income Q2 2025 · Dec 31, 2024 −$232.53K
Net Income Q2 2025 · Jun 30, 2024 $531.47K
Net Income Q2 2025 · Dec 31, 2023 $760.2K
Operating Income Q2 2025 · Dec 31, 2024 −$127.35K
Operating Income Q2 2025 · Dec 31, 2023 $818.37K
Gross Profit Q2 2025 · Dec 31, 2024 $480.39K
Gross Profit Q2 2025 · Dec 31, 2023 $1.2M
Cost Of Revenue Q2 2025 · Dec 31, 2024 $23.47M
Cost Of Revenue Q2 2025 · Dec 31, 2023 $22.3M